524518 Stock Overview
Engages in the manufacture and sale of active pharmaceutical ingredients in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Krebs Biochemicals & Industries Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹89.31 |
| 52 Week High | ₹121.50 |
| 52 Week Low | ₹60.00 |
| Beta | 0.47 |
| 11 Month Change | 14.79% |
| 3 Month Change | 7.60% |
| 1 Year Change | 2.77% |
| 33 Year Change | -46.73% |
| 5 Year Change | -0.99% |
| Change since IPO | -67.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524518 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 11.6% | 3.0% | 1.6% |
| 1Y | 2.8% | 54.1% | 36.9% |
Return vs Industry: 524518 underperformed the Indian Pharmaceuticals industry which returned 54.1% over the past year.
Return vs Market: 524518 underperformed the Indian Market which returned 36.9% over the past year.
Price Volatility
| 524518 volatility | |
|---|---|
| 524518 Average Weekly Movement | 5.3% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524518 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524518's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 191 | Jitendra Shah | krebsbiochem.com |
Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.
Krebs Biochemicals & Industries Limited Fundamentals Summary
| 524518 fundamental statistics | |
|---|---|
| Market cap | ₹1.97b |
| Earnings (TTM) | -₹195.67m |
| Revenue (TTM) | ₹527.29m |
3.7x
P/S Ratio-9.8x
P/E RatioIs 524518 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524518 income statement (TTM) | |
|---|---|
| Revenue | ₹527.29m |
| Cost of Revenue | ₹74.80m |
| Gross Profit | ₹452.50m |
| Other Expenses | ₹648.16m |
| Earnings | -₹195.67m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 11, 2024
| Earnings per share (EPS) | -9.08 |
| Gross Margin | 85.82% |
| Net Profit Margin | -37.11% |
| Debt/Equity Ratio | -162.3% |
How did 524518 perform over the long term?
See historical performance and comparison